Search

Your search keyword '"Tomčík, M"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Tomčík, M" Remove constraint Author: "Tomčík, M"
124 results on '"Tomčík, M"'

Search Results

1. Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review

2. Circulating miRNAs in hand osteoarthritis

3. AB1144 THE ROLE OF SYSTEMIC S100A4 LEVELS IN SCLERODERMA AS A PREDICTOR OF TREATMENT RESPONSE AND EARLY PROGRESSION

4. AB1207 RITUXIMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS NON-RESPONSIVE TO CsDMARDs – PRELIMINARY RESULTS OF A PROSPECTIVE, OBSERVATIONAL, MONOCENTRIC STUDY

5. AB1227 SUBCLINCAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THE GENERAL POPULATION

6. POS0232 SYNOVIAL FLUID CRTAC1: A POTENTIAL INDICATOR OF KNEE OSTEOARTHRITIS SEVERITY

7. AB1160 IL-40 ELEVATION IN SYSTEMIC SCLEROSIS: UNRAVELLING A LINK TO DISEASE ACTIVITY, GASTROINTESTINAL INVOLVEMENT, IMMUNE REGULATION AND FIBROTIC PROCESSES

8. POS0433 RELATIONSHIP BETWEEN MIRNA-1-3P, INTERLEUKIN-17 AND TUMOR NECROSIS FACTOR IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

9. POS0439 SCREENING FOR PLASMA BIOMARKERS PREDICTING RADIOGRAPHIC PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A PRELIMINARY STUDY

10. POS1226 CARDIOVASCULAR RISK IN PATIENTS WITH MYOSITIS COMPARED TO THE GENERAL POPULATION

13. POS0480 VITAMIN D AND ITS RECEPTOR (VDR) GENE EXPRESSION IN SKELETAL MUSCLE ASSOCIATE WITH DISEASE AND MUSCLE FUNCTION PARAMETERS IN IDIOPATHIC INFLAMMATORY MYOPATHIES

14. POS0912 THE EFFECT OF A 24-WEEK TRAINING ON METABOLIC PARAMETERS OF SKELETAL MUSCLE CELLS DERIVED FROM PATIENTS WITH ESTABLISHED IDIOPATHIC INFLAMMATORY MYOPATHIES.

15. OP0105 miRNOME PROFILE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

16. AB0678 Subclinical Atherosclerosis and Cardiovascular Risk in Myositis Patients and Healthy Controls: Preliminary Data From a Single-center Cross-sectional Study

17. Validace české verze dotazníku hodnotícího časný záchyt střevních a mimostřevních projevů u pacientů s axiální spondyloartritidou s rizikem vývoje idiopatického střevního zánětu: screeningová kritéria IBD pro pacienty se SpA

22. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training

24. OP0138 CLUSTERIN ASSOCIATES WITH DISEASE MECHANISMS AND INFLAMMATION IN MYOSITIS PATIENTS

25. OP0136 THE INFLUENCE OF LONG-TERM EXERCISE AND IN VITRO EXERCISE-MIMICKING STIMULATION ON THE PRODUCTION OF MYOKINES AND CYTOKINES IN MYOTUBES OF PATIENTS WITH CHRONIC IDIOPATHIC INFLAMMATORY MYOPATHIES

27. FRI0255 BODY COMPOSITION IN SCLERODERMA PATIENTS IS ASSOCIATED WITH DISEASE ACTIVITY, SERUM LEVELS OF INFLAMMATORY CYTOKINES AND PARAMETERS OF NUTRITION AND LIPID METABOLISM

28. THU0358 NEGATIVE CHANGES OF BODY COMPOSITION IN MYOSITIS PATIENTS AND THEIR ASSOCIATION WITH DISEASE SPECIFIC CHARACTERISTICS, PHYSICAL ACTIVITY AND NUTRITIONAL STATUS.

30. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

31. Validace české verze dotazníků hodnotících sexuální funkci a funkci pánevního dna u mužů.

32. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

33. Validation of Czech versions of questionnaires assessing female sexual function and pelvic floor function.

34. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training.

35. Validace české verze dotazníků hodnotících funkční omezení pacientů se systémovou sklerodermií.

36. Validace české verze dotazníků hodnotících únavu a pohybovou aktivitu u pacientů s revmatickými onemocněními: Fatigue Impact Scale (FIS), Multidimensional Assessment of Fatigue Scale (MAF), Human Activity Profile (HAP)

42. Sexuální dysfunkce u systémové sklerodermie.

43. Gastrointestinální postižení u systémové sklerodermie - jeho následky a strategie terapie.

44. Nefarmakologická terapie u idiopatických zánětlivých myopatií - cvičení a jeho účinky na pacienty s IZM, od roku 1993 až po dnes.

46. Nefarmakologická terapie u systémové sklerodermie.

47. Ateroskleróza a kardiovaskulární riziko u pacientů se systémovou sklerodermií.

Catalog

Books, media, physical & digital resources